L. E. Davydova
L. E. Davydova has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Valentina Gerasimova
North-Eastern Federal University named after M.K. Ammosov
2 shared publications - A. R. Ermolaev1 shared publication
- Albina A. Ivanova
M.K. Ammosov North-Eastern Federal University
1 shared publication - Andrey Yu. Bulanov
N.V. Sklifosovsky Research Institute for Emergency Medicine, Moscow, Russia
1 shared publication - Dmitriy S. Tikhomirov
National Medical Research Center for Hematology of the Ministry of Health of Russia
1 shared publication - E. A. Kravtsova
Gomel city polyclinic No. 1; Gomel city clinical hospital No. 2
1 shared publication
Latest Publications
- 30 December 2025
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 4,p. 88-91
Detection of antibodies to the nuclear antigen of hepatitis B virus in donors from Yakutia as a method of enhancing viral safety
Identifying donors with latent infection and a history of viral hepatitis, followed by their exclusion from donation, is one method for harvesting virus-safe blood components and, consequently, minimizing the risk of post-transfusion complications. To this end, an analysis of the results of a study on antibodies to the hepatitis B core antigen (anti-HBcore) was conducted in donors at the Sakha Republic (Yakutia) Blood Transfusion Center in 2021-2024. During the entire study period the overall detection rate of anti-HBcore was 26.3%, with no statistically significant gender-based difference (25.3% in men vs. 28.2% in women; p = 0.912). Donor age appeared to be one of the main factors influencing anti-HBcore prevalence: the lowest frequency of anti-HBcore was observed in the 21-30 age group – 3.8%, in the 41-50 age group – 58.8%, and in the group over 50 years – 41.0%. Based on the analysis of the obtained results, it is proposed to determine anti-HBcore with each donation for donors over 30-35 years of age.
- 30 December 2025
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 4,p. 88-91
Detection of antibodies to the nuclear antigen of hepatitis B virus in donors from Yakutia as a method of enhancing viral safety
Identifying donors with latent infection and a history of viral hepatitis, followed by their exclusion from donation, is one method for harvesting virus-safe blood components and, consequently, minimizing the risk of post-transfusion complications. To this end, an analysis of the results of a study on antibodies to the hepatitis B core antigen (anti-HBcore) was conducted in donors at the Sakha Republic (Yakutia) Blood Transfusion Center in 2021-2024. During the entire study period the overall detection rate of anti-HBcore was 26.3%, with no statistically significant gender-based difference (25.3% in men vs. 28.2% in women; p = 0.912). Donor age appeared to be one of the main factors influencing anti-HBcore prevalence: the lowest frequency of anti-HBcore was observed in the 21-30 age group – 3.8%, in the 41-50 age group – 58.8%, and in the group over 50 years – 41.0%. Based on the analysis of the obtained results, it is proposed to determine anti-HBcore with each donation for donors over 30-35 years of age.
- Open Access
- 29 November 2021
- Published by EKOlab in Russian Clinical Laboratory Diagnostics
- Vol. 66 (11) , 661-665
AB0 and rhesus blood groups as a risk factor for ARVI COVID-19
The frequency of AB0 and Rhesus blood groups was studied in 12120 patients with COVID-19, 5180 convalescent plasma donors and 118801 healthy donors from Moscow, Smolensk, Yakutsk, Minsk and Gomel. In infected individuals, the frequency of blood group A was significantly higher than in uninfected individuals (41,54 % and 34,39 % respectively, p<0,05), and the frequency of blood group 0, on the contrary, was significantly lower (27,69 % and 36,71 %, p<0,05). The frequency of blood group A was particularly high among patients who died from ARVI COVID-19 - 45,51 % vs. 34,39 %, p=0,008. In some groups of patients, there was a decrease in the frequency of Rh-negative individuals (2,23 % vs. 8,30 %, p<0,001).
- 29 November 2021
- Published by EKOlab in Russian Clinical Laboratory Diagnostics
- Vol. 66 (11) , 661-665
Open AccessAB0 and rhesus blood groups as a risk factor for ARVI COVID-19
The frequency of AB0 and Rhesus blood groups was studied in 12120 patients with COVID-19, 5180 convalescent plasma donors and 118801 healthy donors from Moscow, Smolensk, Yakutsk, Minsk and Gomel. In infected individuals, the frequency of blood group A was significantly higher than in uninfected individuals (41,54 % and 34,39 % respectively, p<0,05), and the frequency of blood group 0, on the contrary, was significantly lower (27,69 % and 36,71 %, p<0,05). The frequency of blood group A was particularly high among patients who died from ARVI COVID-19 - 45,51 % vs. 34,39 %, p=0,008. In some groups of patients, there was a decrease in the frequency of Rh-negative individuals (2,23 % vs. 8,30 %, p<0,001).
- Open Access
- 2 September 2021
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 66 (2) , 242-252-252
The frequency of detection of anti-HBc in blood donors from four regions of Russia
Introduction. Occult hepatitis B virus (HBV) revelation in HBV nuclear antigen testing is of particular importance to prevent transfusion infection.Aim — the identification of factors affecting the anti-HBc detection rate in donated transfusable blood components from different regions of Russia.Materials and methods. A cohort screening single-stage epidemiological study was conducted with 2,000 donor blood samples, 500 samples per each of four regions of the country, the Republics of Crimea (Simferopol) and Sakha (Yakutia), the cities of Saransk and Orenburg. Data on 968 blood samples from the National Research Center for Hematology’s donor bank were used as reference. The testing targeted HBV nuclear antigen antibodies. Positive donated blood samples were additionally tested for IgM and virus surface antigen antibodies using Abbott and Vector-Best commercial reagent kits.Results. Donor demographic profiles differed insignificantly across members of the Russian Federation. Males predominated among the donors (69.6 %). Anti-HBc was detected in 219 of 2,000 samples examined (10.9 %). The donor blood sample anti-HBc detection rate ranged from 6.0 to 21.6 %, depending on the region. Anti-HBc-positive proportions in Orenburg, Crimea, Mordovia and Sakha comprised 8.2, 8.0, 6.0 and 21.6 %, respectively (p < 0.01). First-time donors had anti-HBc in 8.06, regular donors — in 11.29 % cases. The anti-HBc detection rate varied with donor’s age, being zero or near 1 % in 20-yo or younger people. Acute HBV antibodies had zero rate in Orenburg at zero or low-titre (< 100 mIU/mL) protective antibodies; 31 total samples, 15 low-titre and 16 negative for protective antibodies. In Simferopol, acute phase antibodies were negative in 7 blood samples containing high-titre protective antibodies (> 100 mIU/mL) and in 5.0 % samples with their low or zero levels. In Yakutian donors, acute phase antibodies were revealed only at protective antibodies negative. In Saransk, this marker was equal-proportion at zero and high-titre protective antibodies (3.3 % each).Conclusion. Transfusion component procurement from younger donors should be prioritised as enhancing haemotransfusion viral safety. Positive occult HBV tests were less common in regions with low HBV incidence.
- 2 September 2021
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 66 (2) , 242-252-252
Open AccessThe frequency of detection of anti-HBc in blood donors from four regions of Russia
Introduction. Occult hepatitis B virus (HBV) revelation in HBV nuclear antigen testing is of particular importance to prevent transfusion infection.Aim — the identification of factors affecting the anti-HBc detection rate in donated transfusable blood components from different regions of Russia.Materials and methods. A cohort screening single-stage epidemiological study was conducted with 2,000 donor blood samples, 500 samples per each of four regions of the country, the Republics of Crimea (Simferopol) and Sakha (Yakutia), the cities of Saransk and Orenburg. Data on 968 blood samples from the National Research Center for Hematology’s donor bank were used as reference. The testing targeted HBV nuclear antigen antibodies. Positive donated blood samples were additionally tested for IgM and virus surface antigen antibodies using Abbott and Vector-Best commercial reagent kits.Results. Donor demographic profiles differed insignificantly across members of the Russian Federation. Males predominated among the donors (69.6 %). Anti-HBc was detected in 219 of 2,000 samples examined (10.9 %). The donor blood sample anti-HBc detection rate ranged from 6.0 to 21.6 %, depending on the region. Anti-HBc-positive proportions in Orenburg, Crimea, Mordovia and Sakha comprised 8.2, 8.0, 6.0 and 21.6 %, respectively (p < 0.01). First-time donors had anti-HBc in 8.06, regular donors — in 11.29 % cases. The anti-HBc detection rate varied with donor’s age, being zero or near 1 % in 20-yo or younger people. Acute HBV antibodies had zero rate in Orenburg at zero or low-titre (< 100 mIU/mL) protective antibodies; 31 total samples, 15 low-titre and 16 negative for protective antibodies. In Simferopol, acute phase antibodies were negative in 7 blood samples containing high-titre protective antibodies (> 100 mIU/mL) and in 5.0 % samples with their low or zero levels. In Yakutian donors, acute phase antibodies were revealed only at protective antibodies negative. In Saransk, this marker was equal-proportion at zero and high-titre protective antibodies (3.3 % each).Conclusion. Transfusion component procurement from younger donors should be prioritised as enhancing haemotransfusion viral safety. Positive occult HBV tests were less common in regions with low HBV incidence.